Can-Fite BioPharma CANF
NYSE CANF
$2.20 -0.01 (-0.46%)
As of: Oct 2, 2026 · 1:33 PM EDT

Can-Fite BioPharma (CANF) Change in Account Payables (2013)

Updated

Can-Fite BioPharma's Change in Account Payables came in at $543,000 for FY2025, up 184.3% from $191,000 in FY2024.

Analysis

Can-Fite BioPharma (CANF) Change in Account Payables (2013) Analysis & Trends

Going back to FY2015, Can-Fite BioPharma's Change in Account Payables data covers 11 years.

  • The FY2025 figure represents the highest annual Change in Account Payables since FY2019.
  • Per Business Quant, earlier years put Change in Account Payables at $191,000 in FY2024, -$469,000 in FY2023, -$58,000 in FY2022 and $393,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -70.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 18.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -66.70 Mn
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 -336,000.00
API Access

Can-Fite BioPharma Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=CANF&period=max&api_key=YOUR_API_KEY